ResMed (RMD)

R&D Expense Growth

14.19%

Fiscal year · Period ending:

RMD logo

RMD R&D Expense Growth

Latest reported14.19%
RMD FY R&D Growth (YoY) (0.00% → 14.19%)
High-resolution chart · PNG

RMD r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

ResMed R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
14.1875%
7.7259%
6.9124%
13.4347%
12.5579%
11.5566%
11.7879%
16.4371%
7.3941%
21.7579%
3.296%
-2.8429%
-1.58%
9.4693%
19.2659%
22.3465%
19.2622%
4.1835%
20.7919%
34.6356%
23.9955%
14.693%
27.4423%
37.7197%
33.77%
31.1448%
30.7538%
30%
31.5789%
35.7143%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.